Michael Jackson Apparently Co-invented The Anti-Gravity Effect

June 27, 2009

The late, great black white entertainer, Michael Jackson, who was, well weird, even by pop-star standards, was apparently not merely a great singer, dancer and nutter, but also an inventor.

Jackson is listed as one of the co-inventors of the technology used to apparently overcome gravity, used in “Smooth Criminal”, the seventh single from Michael Jackson‘s Bad album, United States Patent 5,255,452, granted in 1993 for a “method and means for creating anti-gravity illusion.” I don’t understand why he called his album bad. I think it was quite good actually.

That as may be, the only magician I know who uses the effect is my old friend, the French born clown who performs in Israel under the name Cris l’Artiste. I don’t recall any reference to the illusion in my fairly large library of magic literature, which includes most of the classic works on stage illusions. The IPKAT, one of my favorite IP blogs, claims that tap-dancing trumpeter Roy Castle performed the stunt on British television in the Sixties. That was before my time, however. But I remember the host of the long-running Record Breakers BBC television series fondly. 

Surprisingly, the stunt is performed by the tin woodman in the classical MGM film, the Wizard of Oz! At the end of a tap-dance, the tin woodman, played by Jack Haley, sways around in anti-gravity circles with his feet flat on the ground. I assume the basic technique is the same as that created by Jackson, which therefore lacks inventive step. That said, I would not bother requesting reexamination. 

For non-phyisicists amongst my readers, the effect in question appears to defy the well established phenomenon that when the center of gravity of an object is not above the base, it tends to topple over. Thus where Jackson and his supporting dancers appear to lean forward so their midpoint is no longer above their feet, they should fall flat on their faces. This is all based on the assumption that the body has more or less constant density throughout. I used to think that Jackson achieved the effect by having a lobotomy along with the extensive surgery he underwent.

Incidentally, there are also easier, less painful and safer ways to perform colour changes, but I digress…

Back to defying gravity, for a less mundane approach, see: Anti-gravity Patent: the United States Patent Office Looking Patently Foolish


Teva, Sandoz and Mayne Do Not Infringe Eloxatin Patents

June 25, 2009

The U.S. District Court of New Jersey has granted summary judgment against Sanofi-Aventis in favor of Israel’s Teva and to Sandoz and Mayne Pharma (Hospira), establishing that patents for Oxaliplatin (Eloxatin) are not infringed by injection.

 Eloxatin is protected by a number of patents: US5,338,874 (Expiry Apr 07,2013) US5,420,319 (Expiry Aug 08,2016) US 5,716,988 (Expiry Aug 07,2015) US 5,290,961 (Expiry Jan 12, 2013) xaliplatin was discovered in 1976 at Nagoya City University in Japan by Professor Yoshinori Kidani, who was granted US4169846 over the drug in 1979. This has now expired. Oxaliplatin is a platinum-based chemotherapy drug that is typically administered in combination with fluorouracil and leucovorin and used to treat colorectal cancer. Eloxatin gained European approval in 1999 and USFDA approval in 2004.


Aussie Men at Work get a helping hand from Girl Guides!

June 25, 2009

The Men At Work hit “Down Under is being sued by Music publishing company Larrikin which owns the rights to the “Kookaburra” song, claiming tha the melody that accompanies the line “Kookaburra sits in the old gum tree” is reproduced in “Down Under.”

 

The problem is that the lawyers for “Down Under” songwriters, Colin Hay and Ron Strykert, and music giants, Sony BMG Music Entertainment, Sony DADC Australia, EMI Songs Australia and EMI Music Publishing are claiming that Larrikin doesn’t actually have copyright to “Kookaburra” but the Australian Girl Guides do.

According to court documents, lawyers for the songwriters and the record companies will argue “the Down Under work does not incorporate the whole or any substantial part of the “Kookaburra work.”


Should Israel Patent Office Host Training Events for Patent Attorneys?

June 24, 2009

Following a successful two day visit by senior European computer technology Examiners to the Israel Patent Office, where one day was for Examiners and a second day for practitioners in private practice, the Israel Patent Office has announced a forthcoming second event, this time focusing on chemistry patenting.

I am very pleased that the patent office is running internal seminars for training their examiners, and hope that the standards of Israel searches and examination will approach that provided by Examiners at the EPO. Since workers of the EPO have to speak three languages and have a tax-free EU civil service salary, whereas in Israel, civil service salaries are not all they could be, I can’t see it happening. That as may be, I view this development of the Israel Patent Office training patent attorneys to work opposite them with some concern. It should be appreciated that we sit on different sides of the fence, and it is the job of private practitioners such as myself to try to stretch the boundaries of what is patentable (unless we are opposing a third party’s application). I think this development is basically unhealthy. Having high level seminars hosted by bodies other than patent attorney firms is, however, healthy. I’d prefer the AIPI / AIPPI / AIPA to be more active in running events training patent attorneys, and obviously they could coordinate with the patent office to bring over speakers.  The new international IP school at Haifa University or the IP at Work initiative at ONO could also host such events.

We also note that the last Patent Office event was limited to only 30 participants anyway and the list of registrants was also  handled in an amateurish way. Although registered, I had to go abroad on business at short notice, so missed the previous event itself, which is a shame, but I understand it was very well put together.


Deputy Commissioner of Patents Rules that Successfully Opposing Independent Claims is Sufficient to Invalidate Entire Patent

June 23, 2009

In an interesting Opposition proceedings regarding Israel Allowed Application No. 133307 to Handasat HaSapak LTD. (Literally, Power-Supply Engineering LTD.), the Deputy Commissioner of Patents and Adjudicator of Intellectual Property, Noach Shalev Shmulovich accepted opposer’s arguments that the Independent Claim 1 for transformer circuit for fluorescent lighting was effectively anticipated by a diagram in a classic Russian text book by Costenko and Pyutrovski that was published in Hebrew in 1965.

fluorescent light 

The remaining claims 2 to 9 added additional features to the main claim.

In addition to the text book, the opposers additionally cited a couple of German patents from the 1930s.

The applicant, represented by Patent Attorney and Advocate Daniel Freiman (himself an electrical engineer), alleged that the main invention was found in dependent claim 5.

As an employee at Seligsohn & Gabrieli, I worked on the original opposition that was filed by Adv. Adi Levit on behalf of Menora Pikud V’bakara LTD. (lit. Lighting Control and Monitoring LTD.), and am not surprised that the Opposition was successful. A second opposer, Handasat Heniah LTD. (lit. Motion Engineering LTD), represented by Adv. Kaldaron took over at some stage.

 There are two obiters in the decision that I am unhappy with however.

Harking back to his mistaken statement in Giraffa vs. Melenick ,  Shmulovich ruled that where applicant is overly greedy in claiming more than he is entitled to, it is sufficient to destroy the main claim, and all dependent claims fall as well.

Now the Applicant may well have been unaware of the Russian textbook, even if translated into Hebrew 40 years earlier. Similarly, the applicant may well have been unaware of a couple of obscure German patents that aren’t available on line. I beleive that attempting to claim a generalized circuit widely and to establish fall back positions is legitimate patent practice. We note that the Examiner, supposedly an expert in electrical engineering, who sees very many applications and is supposed to be familiar with the field, accepted the main claim. Furthermore, I assume that Daniel Freimann, founder of the AIPI and respected Israel IP Author conscientiously drafted and filed claim 1 in good faith. Whether in proscution, during an opposition proceedings or in contentious litigation in enforcing a subsequent patent, if the monopoly of claim 1 should be considered too wide due to prior art coming to light, the monopoly defined by a dependent claim should be an aceptable fall-back position if the monopoly defined is novel and inventive.   I believe that the purpose of the opposition proceedings is to enable interested parties to bring substantive reasons to the consideration of a higher authority to reconsider the patent. In my opinion, the adjudicator should consider each and every claim substantively, not content himself with the main claims.

Additionally, the Adjudicator made an issue of the opposer supplying additional material, i.e. the German patents at a late stage of the proceedings and claimed not to accept them as evidence but merely as indicative of the state of the art (whatever that means). There is no reason to believe that these publications were deliberately withheld, and every reason to assume that the opposer was simply unaware of the additional prior art until later on. If a patent oppositon proceedings was a regular civil matter between two parties, this approach would be acceptable. Indeed it is based on standard civil procedural law. However, in the case of oppositions, the opposer is acting in the public interest and the Patent Office should consider all issues when raised, so long as the proceeding is still taking place and unless there is reason to assume intentional obfustication – which can happen, since there opposer has an interest in drawing out proceedings. Nevertheless, if the adjudicator wants to punish the opposer or compensate the applicant for late submission of evidence by the opposer, he can do so when awarding costs. 

One footnote, we note that all of the parties seem to have very literal names. Not the sort that would be easy to trademark!


Safta’s Soap is Considered Distinctive and Non-diluting

June 22, 2009

In a ruling regarding Opposition to IL 172331, the arbitrator of Intellectual Property, Noach Shalev Shmulovich has ruled that “Sabon Shel Safta” – literally Granny Soap is acceptable for trademark registration despite opposition from Safta Gemila, Medicinal Soap LTD.

Safta Gamila - medicinal soap from Pekiin

Safta Gamila - medicinal soap from Pekiin

The ruling considers that the generic term granny is not descriptive but is merely a hint at traditional, home-made rather than industrial.

Fair enough, and the ruling jumps through the usual hoops regarding phonetic and visual similarity, generic descriptiveness and dilution. Nevertheless, I find the ruling has basic inconsistencies with other recent Israel trademark rulings by Assistant Commissioner Shmulovich who claims that Safta Jemila, Medicinal Soap LTD. is not a well known mark, but went on to rule that even if it were, since the word safta or grandma is generic and merely hints at properties of the soap, the mark would still be allowable.

 This is totally opposite to the ruling re Virgin Candles, hinting at fabrication from olive oil (for sacramental purposes – shabbat and Chanucka candles)

shabbat candles

where term virgin is often used in conjunction with olive oil as indicative of purity.

virgin candle

That mark was disallowed following opposition from Virgin Enterprises, but Richard Branson doesn’t make candles and didn’t have a registration in the class.


Katy Perry Vs Katie Perry

June 22, 2009

Katy Perry, the American pop singer whose real name is Katheryn Elizabeth Hudson is attempting to block an Australian fashion designer from trade-marking her clothing range with the brand name Katie Perry.

The designer, who started her high-end Katie Perry lounge wear label two years ago, apparently filed a trademark application in September 2008 and recently opened her first outlet in Sydney. She has, however received a cease-and-desist order from representatives of the EMI-signed artist, who are attempting to prevent the “similar name” being used in connection with the clothing label.

The problem is that the Australian businesswoman was named Katie Jane Perry as a baby, although is also known as Katie Howell.

The American pop singer, Katheryn Elizabeth Hudson, (called Katy Perry – although not her name) has become a mainstream star in Australia, with hits including “I Kissed A Girl” and “Hot N Cold”.   She is booked to tour Australia this August, beginning Aug. 12 in Brisbane.

This is reminiscent of The White Knight explanation about the song named “A-sitting On a Gate” that is called “Ways and Means”, having the song’s name that is “The Aged Aged Man” but which is called Haddocks’ Eyes.

There are a fair number of similar cases that have gone to court in various jurisdictions. Lego tried to stop a Ms Lego from opening up an art gallery in Denmark. Yoko Ono tried to stop a flower child named Lennon from singing country and Western under that name. generally, something being one’s birth name is a good excuse.


Single Mother ordered to pay $1.92 Million for illegally downloading 24 songs

June 22, 2009

Capitol Records sued Jammie Thomas-Rasset for illegally downloading 24 songs from the file sharing program Kazaa. A federal court jury has found her guilty and liable for $1.92 million in damages, or $80,000 per song. since under the Copyright Act she could have been forced to pay up to $150,000 per song, despite being bankrupted, Ms. Thomas-Rasset could consider herself lucky. The Recording Industry Association of America’s has either sued or threatened to sue more than 30,000 others that have been caught downloading music or file sharing. The other alleged criminals chose to settle out of court, with the downloaders forking out average settlements of $3,500. This is the second trial for Thomas-Rasset. In September 2008 the first trial was declared a mistrial when it was determined that the judge had misdirected the jury. In that ruling, Thomas-Rasset was ordered by pay only $222,000 – still more than $6,000 per song. the French Premier tried to legislate a three strikes and you are banned from using the Internet Law, but was over-ruled by the courts. Apparently French style basic human rights now include liberty, equality, freedom and Internet access. We wonder if there will be a US Pirate’s Party? Since a second rate actor became president and a body builder governor of a State, it is not impossible. I consider this ruling a little disproportionate to damage done, but I suppose that is the point of punitive damages.


Israel Patent Office Voids Smithkline Beecham Patent for Metastable Polymorph

June 21, 2009

Israel generic pharmaceutical manufacturer and patent buster Unipharm has succeeded in preventing Israel Patent Number IL 117035 from issuing.

WMUCAYLIVK2CAI3NMVBCAJIRPX6CA65V1NUCAFLPLEQCA6Z8UA0CAV1MSCRCA82BS6UCAPGIWHNCAXRKBABCAED2ZYUCAQ5PFSPCAHL2FJ6CA58H7CKCAEI7CRFCA5W4K7MCAZ7X2MZCAJSX4KOCAZCS82X

The patent, titled “Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it” claimed novelty for a metastable anhydrate and for the method of manufacture. The composition is claimed to be useful in treating a number of medical disorders including alcoholism, anxiety, depression, anorexia, obesity and pre-menstrual syndrome.

the problem is that an earlier British Patent issued to the same applicant, Smithkline Beecham, GB 26407 claims the same anhydrous salt, together with a method of fabrication. Apparently, the previous method was tried and tested, did work back then, but no longer does so, yielding instead, the stabler hemi-hydrate. As anyone trying out these tricky syntheses will testify, its rather like trying to bake a mother’s cake, in that following the recipe is insufficient. Without the right tempo of stirring, the right impurities in the water, or whatever, the results bear some similarity but are, nevertheless, different.

The applicant claimed that in this new synthesis the anhydrate was obtained by the stage of washing with an aqueous solution, which would appear to be sufficiently counter-intuitive that it provides an inventive step.

Since in the opposition proceedings the applicant failed to pursue the method of manufacture, even as a fall-back position, but went full steam ahead for the product, the Arbitrator of Intellectual Property, Noach Shalev Shmulovich, ruled that the method claims are void as well. He justified this position by claiming that applicant had failed to point out the existence of the UK application in contravention to duty of disclosure under Section 18, citing 14/92 Nazareth District Court (Pelason Maagan Michael Factories LTD. vs. Freddy Freenet), that failure to disclose Prior Art known to applicant can invalidate patent (not just citations). 

The decision leaves some open issues however: claims 15-17 are independent method claims and why should the existence of the product by a different processing route cancel these?

Applicant asserted that mentioning a European application that claims priority from the British patent essentially incorporated it by reference and thus it was disclosed. Shmulovich is correct that this argument is weak, but one notes that the Commissioner of Patents has requested to only submit prior art cited in corresponding applications and not to submit all art known to applicants. Personally I advocate supplying details of all art known to applicant, and do so (I note that this was the general recommendation of Agents of Applicant Luzzatto et Luzzatto – at least at the time I worked there at the beginning of my career).   

Of note, Shmulovich took the opportunity to admit his mistake and to cancel his ruling concerning IL 142049 Giraffa vs. Melnicke  where he’d mistakenly decided that should an independent claim be disqualified, the dependent claims fall with it. No-one took the ruling seriously; nevertheless it takes guts to state that one was wrong and we salute him for so doing.

Unipharm was represented by Adi Levit and Smithkline  Beecham by Richard Luthi and Co.

In a second case, published at the same time, the Arbitrator of Patents rejected Unipharm’s opposition and upheld Smithkline Beecham’s Patent Number 133,137 for the combination of Rosiglitzone RSG and sulhponylurea useful for the treatment of diabetes, despite the combination being disclosed in an earlier patent (EP749751) to Takeda. In this case the Arbitrator of Intellectual Property ruled that specific dosages provided a surprising synergy that enabled maintaining a constant blood sugar level over time and thus constituted novelty and inventive step.


L’Oreal wins decision against Bellure to prevent Comparative Advertising

June 21, 2009

The European Court of Justice has ruled in favour of L’Oreal, preventing Bellure from selling cheaper smells-like fragrances in look-alike packages with comparative advertising.

l'orealAnais_Anais_mw

Lord Jacob felt that comparative advertsing was OK, but referred case to the European Court of Justice who ruled that “an advantage taken by a third party of the distinctive character or the repute of the mark may be unfair, even if the use of the identical or similar sign is not detrimental either to the distinctive character or to the repute of the mark or, more generally, to its proprietor”.

I have a problem with the ruling in that it lacks balance. It does not address the issue of when a fragrance should enter the public domain.

In Israel, scents cannot be trademarked, nor can bottle shapes unless ruled as having aquired distinction through use. They can be registered as designs though – but only for a limited period. This is because trademarks are supposed to indicate the source of the product, not protect the product itself.

If pharmaceutical compositions that are novel and inventive have a 20 year from inception / 9 year from commercialization limited monopoly, why should a scent be protected from copying indefinately? trade-dress and passing off is one thing, but here we are talking about smell-alike clones that are sold as such.

I am inclined to favor cheaper generics sold as such in much the same way as I favor non-branded jeans and supermarket brands of instant coffee or generic colas.

Trademarks are indefinately renewable, and so I find the European Court of Justice’s ruling lacks balance, and would be happy to see the Swedish Pirate Party trying to legislate a more balanced decision through the European Parliament.


Follow

Get every new post delivered to your Inbox.

Join 90 other followers